THIS PRODUCT MAY NOT BE RIGHT FOR YOU. ALWAYS READ THE LABEL, WARNINGS AND INSTRUCTIONS FOR USE, BEFORE PURCHASE. VITAMIN AND MINERAL SUPPLEMENTS SHOULD NOT REPLACE A BALANCED DIET.

A supplement that helps improve overall skin health!

• Supports formation of collagen and skin elasticity.
• Supports skin regeneration.
• Improves overall skin appearance.

Product Description

Swisse Beauty Skin Defence Ultiratrol is a premium supplement that's formulated to support skin regeneration and health, at the same time maintains skin elasticity and formation of collagen. It contains resveratrol, grape seed and nicotinamide which helps to reduce free radical damage and help maintain general wellbeing.

Active Ingredients

Each Tablet Contains:

VITAMIN B3 (Nicotinaminde) 10mg;

VITAMIN C (ascorbic acid from calcium ascorbate dihydrate) 11.25 mg;

VITAMIN E (d-alpha-tocopheryl acid succinate 2.25 IU ) 1.86 mg;

ZINC (from zinc gluconate) 2.5 mg;

GRAPE SEED (Vitis vinifera extract 41.67 mg) equiv. dry seed 834 mg (standardised to contain procyanidins (of vitis vinifera) 33.34 mg) min. 4.58 g;

Knotweed (Reynoutria japonica extract 222 mg) equiv. dry root [standardised to contain resveratrol (of reynoutria japonica) 111 mg] min. 20 g

Directions For Use

Two tablets daily, during or immediately after a meal, or as directed by a healthcare professional.

Warning

Vitamin supplements should not replace a balanced diet.

Contains soya bean and sulfites.

About Swisse

Swisse is an Australian success story. It all began with founder Kevin Ring in a humble Melbourne warehouse in 1969. From the outset, our mission was embedded in the Swisse DNA - a dream to make people all over the world healthier and happier. Today, the Swisse product range stretches from top selling men's and women's multivitamins and dietary supplements, to sports nutrition, skincare and functional foods. Swisse products are currently available in Australia, New Zealand, China, Singapore, the UK, Italy and the Netherlands, with plans to launch in up to 30 countries in the next five years.